Polybenzoxazine coatings that outperform Teflon without using fluorine atoms. They offer lower surface free energy, higher thermal stability, and greater scratch resistance, making them ideal for high-temperature, non-stick, and chemically resistant applications.
This technology offers a new class of thermosetting coatings based on polybenzoxazine, a polymer that achieves lower surface free energy than Teflon without relying on fluorine chemistry. The unique molecular structure forms a six-membered intramolecular hydrogen bond at the surface, producing a highly hydrophobic yet fluorine-free coating with exceptional thermal stability, mechanical strength, and release properties. The material is durable to 400°F and exhibits thermal stability up to 450°C, making it a strong candidate for industries seeking high-performance, environmentally friendly alternatives to fluoropolymer coatings.
Key features and benefits:
How it works:
The polymer's unusual properties arise from a six-membered intramolecular hydrogen bond between electron-rich nitrogen and electron-deficient phenolic hydrogen. High-resolution solid-state 1H NMR spectroscopy confirmed this structure by detecting shared proton signals between oxygen and nitrogen atoms. This intramolecular bonding is responsible for the polymer's high Tg, thermal stability, mechanical strength, and low surface free energy.
The polybenzoxazine platform has been studied and validated since its first publication in 1994, with solid evidence of the six-membered intramolecular hydrogen-bonded structure confirmed through high-resolution solid-state NMR. The polymer has demonstrated superior thermal and surface properties relative to Teflon in published research. Future validation efforts will focus on identifying polybenzoxazine formulations with Tg above the required temperature limits, optimizing blend compositions for scratch resistance and ultra-low surface energy, and evaluating the release of any potential toxic gases during processing and use.
Case Western Reserve University is a comprehensive private research university anchored in Cleveland’s University Circle with a high‑intensity research enterprise. Its campus is co‑located with major hospital systems, giving industry partners access to clinical collaborators, regulatory know‑how, and real‑world validation environments. A large open‑access makerspace, shared core facilities, and an engineering co‑op program connect companies to rapid prototyping, testing, and talent pipelines. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DoD. A dedicated technology transfer office, working with corporate engagement and entrepreneurship programs, supports IP strategy, licensing, sponsored research, and startup formation.